These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 8627576

  • 1. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.
    Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Aposhian MM, Dart RC, Woods JS, Ostrosky-Wegman P, Gonsebatt ME, Aposhian HV.
    J Pharmacol Exp Ther; 1996 May; 277(2):938-44. PubMed ID: 8627576
    [Abstract] [Full Text] [Related]

  • 2. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride.
    Gonzalez-Ramirez D, Zuniga-Charles M, Narro-Juarez A, Molina-Recio Y, Hurlbut KM, Dart RC, Aposhian HV.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315
    [Abstract] [Full Text] [Related]

  • 3. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
    Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Aposhian MM, Dart RC, Diaz Gama JH, Echeverria D.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):264-74. PubMed ID: 7815341
    [Abstract] [Full Text] [Related]

  • 4. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
    Aposhian HV, Arroyo A, Cebrian ME, del Razo LM, Hurlbut KM, Dart RC, Gonzalez-Ramirez D, Kreppel H, Speisky H, Smith A, Gonsebatt ME, Ostrosky-Wegman P, Aposhian MM.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
    Nerudová J, Cábelková Z, Frantík E, Lukás E, Urban P, Bláha K, Pelclová D, Lebedová J, Cikrt M.
    Int J Occup Med Environ Health; 2000 Nov; 13(2):131-46. PubMed ID: 10967843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The mercury exposure of the population. III. Mercury mobilisation by DMPS (Dimaval) in subjects with and without amalgam fillings].
    Zander D, Ewers U, Freier I, Brockhaus A.
    Zentralbl Hyg Umweltmed; 1992 Feb; 192(5):447-54. PubMed ID: 1554403
    [Abstract] [Full Text] [Related]

  • 12. Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).
    Aposhian HV.
    Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1017-25. PubMed ID: 9703487
    [Abstract] [Full Text] [Related]

  • 13. Urinary excretion of trace elements in humans after sodium 2,3-dimercaptopropane-1-sulfonate challenge test.
    Torres-Alanís O, Garza-Ocañas L, Bernal MA, Piñeyro-López A.
    J Toxicol Clin Toxicol; 2000 Aug; 38(7):697-700. PubMed ID: 11192456
    [Abstract] [Full Text] [Related]

  • 14. Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score.
    Aposhian HV, Bruce DC, Alter W, Dart RC, Hurlbut KM, Aposhian MM.
    FASEB J; 1992 Apr; 6(7):2472-6. PubMed ID: 1563599
    [Abstract] [Full Text] [Related]

  • 15. [Biomonitoring for the evaluation of a mercury burden from amalgam fillings. Mercury determination in urine before and after oral doses of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and in hair].
    Herrmann M, Schweinsberg F.
    Zentralbl Hyg Umweltmed; 1993 May; 194(3):271-91. PubMed ID: 8338616
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blood mercury following DMPS administration to subjects with and without dental amalgam.
    Vamnes JS, Eide R, Isrenn R, Höl PJ, Gjerdet NR.
    Sci Total Environ; 2003 Jun 01; 308(1-3):63-71. PubMed ID: 12738201
    [Abstract] [Full Text] [Related]

  • 19. Color discrimination impairment in workers exposed to mercury vapor.
    Urban P, Gobba F, Nerudová J, Lukás E, Cábelková Z, Cikrt M.
    Neurotoxicology; 2003 Aug 01; 24(4-5):711-6. PubMed ID: 12900084
    [Abstract] [Full Text] [Related]

  • 20. Health consequences of an intravenous injection of metallic mercury.
    Winker R, Schaffer AW, Konnaris C, Barth A, Giovanoli P, Osterode W, Rüdiger HW, Wolf C.
    Int Arch Occup Environ Health; 2002 Oct 01; 75(8):581-6. PubMed ID: 12373321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.